ISPOR—The Professional Society for Health Economics and Outcomes Research announced this week that the Real-World Evidence Transparency Initiative has launched the Real-World Evidence Registry . The initiative is a partnership between ISPOR, the International Society for Pharmacoepidemiology, the Duke-Margolis Center for Health Policy, and the National Pharmaceutical Council.
Read the source article at acrpnet.org
2021-10-29 14:41:47
